Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Interleukin-6, a pleiotropic cytokine

Highly Access

Interleukin-6 and chronic inflammation

Cem Gabay

Arthritis Research & Therapy 2006, 8(Suppl 2):S3 doi:10.1186/ar1917

Accesses  

  • Last 30 days: 397 accesses
  • Last 365 days: 4025 accesses
  • All time: 17552 accesses

Cited by

BioMed Central: 4 citations

Research   Open Access Highly Accessed

Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis

Cecilia K Andersson, Annika Andersson-Sjöland, Michiko Mori, Oskar Hallgren, Annie Pardo, Leif Eriksson, Leif Bjermer, Claes-Göran Löfdahl, Moises Selman, Gunilla Westergren-Thorsson, Jonas S Erjefält Respiratory Research 2011, 12:139 (20 October 2011)

Research   Open Access Highly Accessed

Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis

Bailin Liang, Zheng Song, Bin Wu, Debra Gardner, David Shealy, Xiao-Yu Song, Paul H Wooley Journal of Inflammation 2009, 6:10 (15 April 2009)

Research article   Open Access Highly Accessed

Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study

Kristin Andreas, Carsten Lübke, Thomas Häupl, Tilo Dehne, Lars Morawietz, Jochen Ringe, Christian Kaps, Michael Sittinger Arthritis Research & Therapy 2008, 10:R9 (18 January 2008)

Research   Open Access Highly Accessed

Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease

Elizabeth A Droke, Kelly A Hager, Megan R Lerner, Stan A Lightfoot, Barbara J Stoecker, Daniel J Brackett, Brenda J Smith Journal of Inflammation 2007, 4:17 (7 September 2007)